Total Payments
$244,252
2024 Payments
$29,381
Companies
16
Transactions
294
Medicare Patients
651
Medicare Billing
$82,405
Payment Breakdown by Category
Other$127,882 (52.4%)
Consulting$65,291 (26.7%)
Travel$31,432 (12.9%)
Research$12,163 (5.0%)
Food & Beverage$7,293 (3.0%)
Education$192.48 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $122,862 | 43 | 50.3% |
| Consulting Fee | $65,291 | 45 | 26.7% |
| Travel and Lodging | $31,432 | 72 | 12.9% |
| Unspecified | $12,163 | 10 | 5.0% |
| Food and Beverage | $7,293 | 119 | 3.0% |
| Honoraria | $5,000 | 1 | 2.0% |
| Education | $192.48 | 3 | 0.1% |
| Grant | $19.42 | 1 | 0.0% |
Payments by Type
General
$232,090
284 transactions
Research
$12,163
10 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $112,757 | 97 | $0 (2024) |
| Abbott Laboratories | $56,044 | 83 | $0 (2020) |
| Acorda Therapeutics, Inc | $27,112 | 31 | $0 (2024) |
| Roche Products Limited | $13,595 | 3 | $0 (2017) |
| Medtronic, Inc. | $12,278 | 12 | $0 (2024) |
| US WorldMeds, LLC | $9,727 | 26 | $0 (2018) |
| Medtronic USA, Inc. | $5,662 | 13 | $0 (2020) |
| Allergan, Inc. | $4,640 | 7 | $0 (2021) |
| Boston Scientific Corporation | $1,971 | 12 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $128.62 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29,381 | 31 | ACADIA Pharmaceuticals Inc ($25,137) |
| 2023 | $1,646 | 3 | Medtronic, Inc. ($1,496) |
| 2022 | $6,366 | 9 | Medtronic, Inc. ($6,232) |
| 2021 | $4,062 | 5 | Allergan, Inc. ($3,240) |
| 2020 | $3,657 | 20 | Allergan, Inc. ($1,400) |
| 2019 | $44,703 | 53 | Acorda Therapeutics, Inc ($25,823) |
| 2018 | $65,831 | 91 | ACADIA Pharmaceuticals Inc ($41,854) |
| 2017 | $88,607 | 82 | ACADIA Pharmaceuticals Inc ($44,931) |
All Payment Transactions
294 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $107.26 | General |
| Category: General - DBS_NMD | ||||||
| 10/24/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,500.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/24/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,950.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/05/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $87.99 | General |
| Category: General - DBS_NMD | ||||||
| 10/01/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Travel and Lodging | In-kind items and services | $446.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/01/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $73.93 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 09/28/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $27.25 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 09/21/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Travel and Lodging | In-kind items and services | $362.88 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 09/20/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $58.20 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 09/18/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $30.59 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 09/17/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,600.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 09/14/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Travel and Lodging | In-kind items and services | $1,083.90 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/15/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 07/19/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $117.78 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 07/09/2024 | Medtronic, Inc. | — | — | Cash or cash equivalent | $700.00 | Research |
| Study: ADAPT-PD Trial | ||||||
| 05/17/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $9,500.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/10/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $753.19 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/10/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $607.94 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/10/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $105.06 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/10/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $72.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/10/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $56.65 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/10/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $47.21 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/10/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $40.20 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/10/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/10/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ADAPT-PD Trial | Medtronic, Inc. | $12,163 | 10 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 151 | 300 | $93,625 | $23,938 |
| 2022 | 6 | 158 | 278 | $73,301 | $19,765 |
| 2021 | 7 | 154 | 297 | $70,363 | $20,301 |
| 2020 | 9 | 188 | 314 | $66,604 | $18,402 |
Total Patients
651
Total Services
1,189
Medicare Billing
$82,405
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 61 | 106 | $44,849 | $11,288 | 25.2% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 15 | 43 | $22,091 | $4,722 | 21.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 27 | $7,188 | $2,607 | 36.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $6,577 | $1,840 | 28.0% |
| 95984 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional | Office | 2023 | 11 | 36 | $4,598 | $1,199 | 26.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 14 | $3,924 | $1,035 | 26.4% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 15 | 45 | $2,205 | $703.56 | 31.9% |
| 95983 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | Office | 2023 | 13 | 15 | $2,193 | $543.34 | 24.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 72 | 110 | $42,295 | $11,396 | 26.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 23 | 23 | $11,043 | $3,117 | 28.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 20 | 31 | $8,003 | $2,062 | 25.8% |
| 95984 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional | Office | 2022 | 15 | 60 | $7,401 | $1,997 | 27.0% |
| 95983 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | Office | 2022 | 15 | 21 | $2,942 | $736.72 | 25.0% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2022 | 13 | 33 | $1,617 | $456.14 | 28.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 71 | 118 | $38,806 | $12,073 | 31.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 24 | 24 | $10,776 | $2,775 | 25.8% |
| 95984 | Electronic analysis of implanted brain, spinal cord or peripheral stimulation device with brain stimulator programming, additional 15 minutes face-to-face time with qualified health care professional | Office | 2021 | 11 | 64 | $7,726 | $1,917 | 24.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 12 | 19 | $4,363 | $1,228 | 28.1% |
| 99358 | Prolonged patient service without direct patient contact first hour | Office | 2021 | 13 | 16 | $4,303 | $1,097 | 25.5% |
| 95983 | Electronic analysis of implanted brain, spinal cord or peripheral stimulation device with brain stimulator programming, first 15 minutes face-to-face time with qualified health care professional | Office | 2021 | 11 | 19 | $2,596 | $631.47 | 24.3% |
| 95874 | Needle measurement and recording of electrical activity of muscles for guidance with injection of chemical for destruction of muscles | Office | 2021 | 12 | 37 | $1,793 | $578.55 | 32.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 45 | 61 | $17,644 | $4,922 | 27.9% |
| 95984 | Electronic analysis of implanted brain, spinal cord or peripheral stimulation device with brain stimulator programming, additional 15 minutes face-to-face time with qualified health care professional | Office | 2020 | 17 | 80 | $9,474 | $2,680 | 28.3% |
| 64616 | Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin | Office | 2020 | 12 | 25 | $11,310 | $2,625 | 23.2% |
| 99358 | Prolonged patient service without direct patient contact first hour | Office | 2020 | 25 | 30 | $8,040 | $2,601 | 32.3% |
About Dr. Matthew Brodsky, MD
Dr. Matthew Brodsky, MD is a Neurology healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164430609.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Brodsky, MD has received a total of $244,252 in payments from pharmaceutical and medical device companies, with $29,381 received in 2024. These payments were reported across 294 transactions from 16 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($122,862).
As a Medicare-enrolled provider, Brodsky has provided services to 651 Medicare beneficiaries, totaling 1,189 services with total Medicare billing of $82,405. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Portland, OR
- Active Since 08/03/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1164430609
Products in Payments
- NUPLAZID (Drug) $112,757
- Neuromodulation Dspsbls and Accs (Device) $29,287
- INBRIJA (Drug) $26,847
- DBS IPGs (Device) $21,234
- Non-Covered Product (Drug) $13,595
- Xadago (Drug) $7,712
- ACTIVA (Device) $5,662
- BOTOX (Biological) $4,640
- Proclaim Family of SCS IPGs (Device) $3,055
- MYOBLOC (Biological) $2,000
- Deep Brain Stimulation (Device) $1,453
- SPECTRA WAVEWRITER (Device) $960.02
- Infinity DBS Pulse Generators (Device) $790.72
- GENERAL DBS (Device) $484.87
- GENERAL DBS (Device) $180.41
- Kynmobi (Drug) $121.60
- Dysport 300 U-1 (Drug) $110.85
- SENSIGHT (Device) $95.69
- AUSTEDO (Drug) $91.85
- DAXXIFY (Drug) $73.93
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Portland
Kyle Smoot, M.d, M.D
Neurology — Payments: $944,765
Neurology $944,765
Stanley Cohan, M.d, M.D
Neurology — Payments: $664,935
Neurology $664,935
Dr. Chafic Karam, M.d, M.D
Neurology — Payments: $647,064
Neurology $647,064
Dr. John Dolan, D.o, D.O
Neurology — Payments: $550,588
Neurology $550,588
Kiren Kresa-Reahl, M.d, M.D
Neurology — Payments: $421,575
Neurology $421,575
David Spencer, Md, MD
Neurology — Payments: $101,259
Neurology $101,259